Nanomedicine targeting ferroptosis to overcome anticancer therapeutic resistance

Area of Science:

• Oncology
• Nanomedicine
• Biochemistry

Background:

• Treatment resistance is a significant challenge in chemotherapy, radiotherapy, and immunotherapy, leading to tumor recurrence and metastasis.
• Mechanisms of resistance include inhibited cell death, drug resistance, DNA repair, and altered tumor microenvironments.
• Ferroptosis, a form of regulated cell death dependent on iron and lipid peroxidation, has emerged as a key factor in therapy resistance.

Purpose of the Study:

• To detail the design, mechanism, and therapeutic applications of ferroptosis-mediated synergistic tumor therapeutics.
• To explore the role of ferroptosis in overcoming treatment resistance.
• To discuss the potential of nanomedicine in conjunction with ferroptosis regulation for combination cancer therapy.

Main Methods:

• Review of recent studies on ferroptosis inducers and their role in therapy resistance.
• Analysis of ferroptosis nanoinducers' mechanisms, including direct ferroptosis induction and feedback regulation.
• Discussion of synergistic therapeutic strategies combining ferroptosis with clinical treatments.

Main Results:

• Ferroptosis plays a critical role in tumor therapy resistance.
• Ferroptosis inducers, particularly nanoinducers, can reverse resistance by triggering cell death and feedback regulation.
• Combination therapies utilizing ferroptosis inducers show enhanced anti-tumor effects.

Conclusions:

• Ferroptosis-mediated synergistic therapeutics offer a promising approach to combat tumor treatment resistance.
• Nanomedicine strategies targeting ferroptosis hold significant potential for improving cancer treatment outcomes.
• Further research into ferroptosis regulation and combination therapies is crucial for clinical translation.